The state awarded five life sciences companies $200,000 apiece through the BioMaryland Center, a division within the state Department of Business and Economic Development.
MDBizNews reports:
The companies, which received up to $200,000 each, will use the funding to advance the early detection of Alzheimer’s disease, create a less-invasive treatment for tachycardia patients, enhance animal analgesics, control traumatic bleeds and develop high-quality gluten and allergen-free kosher food products.
Companies receiving awards this round include:
- Baltimore-based Animalgesic Labs, which is manufacturing its first batch of FDA authorized pain medication
- Baltimore-based Cardiosolv, which is undertaking a study to create a less-invasive treatment for tachycardia patients.
- Rockville-based Adlyfe, which is commercializing technologies for the early detection of Alzheimer’s disease
- Columbia-based CrispTek, which is developing and marketing three new certified gluten and allergen-free baking mixes
- College Park-based Remedium Technologies, which is working on advancing its Hemogrip TM, a proprietary lifesaving technology to stop traumatic bleeding.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
Maryland firms score $5M to manufacture everything from soup to nanofiber
National AI safety group and CHIPS for America at risk with latest Trump administration firings
How women can succeed in male-dominated trades like robotics, according to one worker who’s done it
